Sarah Grant

Company: AstraZeneca

Job title: Vice President & Head, Early Clinical Development, Respiratory & Immunology

Seminars:

Targeting CCR9: Advancing Precision Therapies for Inflammatory Bowel Disease 12:00 pm

Leveraging CCR9 inhibition to improve therapeutic targeting and address IBD heterogeneitys Exploring clinical outcomes and patient stratification strategies for CCR9-targeted therapies Innovating treatment pathways to optimize safety and efficacy in precision medicine for IBDRead more

day: Day Two